People With Type 2 Diabetes May Be At Risk For Pancreatitis

	Tweet

While the vast majority of medications that Americans take are both safe and effective, many people may be surprised to discover that certain drugs may not be as safe as they thought. Numerous products are marketed as treatments for diabetes, including Januvia (sitagliptin) and the combination pill Janumet, which contains the drug metformin. Unfortunately, the drugs, manufactured by the pharmaceutical company Merck & Co. for type 2 diabetes, have reportedly caused serious health problems in some patients.

The Food and Drug Administration (FDA) has released an important safety alert about Januvia and Janumet. In that alert, the agency advised the public that it had revised the prescribing information for those medicines to indicate that it had received 88 reports of acute pancreatitis in people using the pills. A reported 66 percent of these patients were hospitalized.

Two cases involved the severe form, hemorrhagic or necrotizing pancreatitis. 

The FDA has asked the health care community to tell patients that persistent, severe abdominal pain, sometimes radiating to the back, which may or may not be accompanied by vomiting, is the hallmark symptom of acute pancreatitis. It also requested that patients promptly discontinue Januvia/ Janumet and contact their physician if persistent severe abdominal pain occurs. Pancreatitis can lead to life-threatening illness.

Certain attorneys have been fighting for the rights of people harmed by defective medicines and medical devices for over 20 years. They would like to help people who took Januvia or Janumet and suffered from acute pancreatitis.

To find out more, visit http://www.weitzlux.com, call 888-411-LAWS (5297) or send an e-mail to .

---
(NAPSI)

RELATED STORIES:
Phone contact with nurses linked with better outcomes for women with gestational diabetes   Death rate drops among Americans with diabetes -CDC   Correct treatment of common diabetic foot infections can reduce amputations   “Pre-diabetes,” diabetes rising among U.S. teens   Experimental bariatric surgery controls blood sugar in rats with diabetes   53 millions Americans might develop diabetes by 2025   New inflammation hormone link may pave way to study new drugs for type 2 diabetes   Diabetic retinopathy research could reduce screening costs   Liver fat gets a wake-up call that maintains blood sugar levels   Low testosterone levels could raise diabetes risk for men   Prosthetic lets diabetic get a foot up on life   Dealing with Diabetes, One Patient at a Time

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]